Cargando…

T Cell Responses Correlate with Self-Reported Disease Severity and Neutralizing Antibody Responses Predict Protection against SARS-CoV-2 Breakthrough Infection

Objectives: The objective of this prospective study was to investigate the role of adaptive immunity in response to SARS-CoV-2 vaccines. Design and Methods: A cohort of 677 vaccinated individuals participated in a comprehensive survey of their vaccination status and associated side effects, and dona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhen, Kumanovics, Attila, Love, Tanzy, Melanson, Stacy E. F., Meng, Qing H., Wu, Alan H. B., Wiencek, Joesph, Apple, Fred S., Ondracek, Caitlin R., Koch, David D., Christenson, Robert H., Zhang, Yan Victoria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058409/ https://www.ncbi.nlm.nih.gov/pubmed/36992418 http://dx.doi.org/10.3390/v15030709

Ejemplares similares

Tolerance for three commonly administered COVID-19 vaccines by healthcare professionals
por: Melanson, Stacy E. F., et al.
Publicado: (2022)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Delta breakthrough infections elicit potent, broad and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2021)

Omicron neutralizing antibody response following booster vaccination compared with breakthrough infection
por: Curlin, Marcel E., et al.
Publicado: (2022)

Clinical Ordering Practices of the SARS-CoV-2 Antibody Test at a Large Academic Medical Center
por: Wiencek, Joesph R, et al.
Publicado: (2020)

Amino Acid Region 1000–1008 of Factor V Is a Dynamic Regulator for the Emergence of Procoagulant Activity
por: Wiencek, Joesph R., et al.
Publicado: (2013)

Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
por: Seaman, Michael S., et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
por: Walls, Alexandra C., et al.
Publicado: (2022)

Neutralizing Antibody Response to Hepatitis C Virus
por: Wang, Yong, et al.
Publicado: (2011)

Vaccine Breakthrough Infection with the SARS-CoV-2 Delta or Omicron (BA.1) Variant Leads to Distinct Profiles of Neutralizing Antibody Responses
por: Seaman, Michael S., et al.
Publicado: (2022)

Andromeda breakthrough /
por: Hoyle, Fred
Publicado: (1970)

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection
por: Evans, John P., et al.
Publicado: (2022)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
por: Yamamoto, Shohei, et al.
Publicado: (2023)

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
por: Seow, Jeffrey, et al.
Publicado: (2023)

Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections
por: Tober-Lau, Pinkus, et al.
Publicado: (2022)

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection
por: Evans, John P., et al.
Publicado: (2021)

Pandemic Response in the Clinical Laboratory: The Utility of Interactive Dashboards
por: Petrides, Athena K., et al.
Publicado: (2022)

Neutralizing antiviral antibody responses
por: Zinkernagel, Rolf M., et al.
Publicado: (2001)

SARS-CoV-2 vaccine antibody response and breakthrough infection in dialysis
por: Anand, Shuchi, et al.
Publicado: (2021)

Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection
por: Zhu, Ka-Li, et al.
Publicado: (2023)

Studies on the Tissue-Related Phenotypic Heterogeneity of Murine B Cells
por: Balogh, Péter, et al.
Publicado: (1998)

Permissive omicron breakthrough infections in individuals with binding or neutralizing antibodies to ancestral SARS-CoV-2
por: Williams, Erin, et al.
Publicado: (2022)

W-particle breakthrough
por: Lipkin, H J
Publicado: (1983)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
por: Möhlendick, Birte, et al.
Publicado: (2022)

Prior vaccination enhances immune responses during SARS-CoV-2 breakthrough infection with early activation of memory T cells followed by production of potent neutralizing antibodies
por: Painter, Mark M., et al.
Publicado: (2023)

Neutralizing Antibody Response and SARS Severity
por: Ho, Mei-Shang, et al.
Publicado: (2005)

Coronavirus diseases 2019 (COVID-19) response: Highlights of Ghana's scientific and technological innovativeness and breakthroughs
por: Sibiri, H., et al.
Publicado: (2020)

COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron
por: Suntronwong, Nungruthai, et al.
Publicado: (2022)

Subcutaneous EEG Monitoring Reveals AED Response and Breakthrough Seizures
por: Weisdorf, Sigge, et al.
Publicado: (2020)

Immune Responses and Breakthrough Infections After COVID-19 Vaccination
por: Kwon, Ki Tae
Publicado: (2023)

Antibody response assessment of immediate breakthrough infections after zero-COVID policy adjustment in China
por: Li, Yanhua, et al.
Publicado: (2023)

An Empirical Method for Establishing Positional Confidence Intervals Tailored for Composite Interval Mapping of QTL
por: Crossett, Andrew, et al.
Publicado: (2010)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
por: Zou, Jing, et al.
Publicado: (2022)

Neutralizing antibody response in mild COVID-19
por: van der Heide, Verena
Publicado: (2020)

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
por: Suthar, Mehul S., et al.
Publicado: (2020)

Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses
por: Jia, Janice Zhirong, et al.
Publicado: (2022)

Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
por: Kared, Hassen, et al.
Publicado: (2022)

Breakthrough!
por: KURNIT, Paul
Publicado: (2010)

Common allergies in urban adolescents and their relationships with asthma control and healthcare utilization
por: Rhee, Hyekyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ocekaphq0ae7bi5hsp97gi5f4o